Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-30 @ 12:14 AM
Study NCT ID:
NCT07310420
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-11
First Post:
2025-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer
Sponsor:
TerSera Therapeutics LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-04-29
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-16
First Submit QC Date:
None
Study First Post Date:
2025-12-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-09
Last Update Post Date:
2026-03-11
Last Update Post Date Type:
ACTUAL